Back
EyePoint Pharmaceuticals Stock Price Chart
The Fed Just Cut Rates-Here's Alex Green's $1 Million AI Stock Picks
Watch Alex Green's breakdown and discover the next big AI winners!
Sell
40
EYPT
EyePoint Pharmaceuticals
Last Price:
8.16
Seasonality Move:
-9.25%
7 Day Trial
ALL ACCESS PASS
$
7
Invest in the Next Big AI Disruptor Today
Learn More- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
EyePoint Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.22 | Sell |
| 20-day SMA: | 8.42 | Sell |
| 50-day SMA: | 8.66 | Sell |
| 200-day SMA: | 15.98 | Sell |
| 8-day EMA: | 8.2 | Sell |
| 20-day EMA: | 8.4 | Sell |
| 50-day EMA: | 8.83 | Sell |
| 200-day EMA: | 12.03 | Sell |
EyePoint Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 42.06 | Sell |
| Chaikin Money Flow: | 232993 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.06 - 8.9) | Sell |
| Bollinger Bands (100): | (8.03 - 10.53) | Sell |
EyePoint Pharmaceuticals Technical Analysis
| Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for EyePoint Pharmaceuticals Stock
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 8.01 while EYPT 8-day simple moving average is 8.22, which is a Sell signal.
- The stock price of EYPT is 8.01 while EyePoint Pharmaceuticals 20-day SMA is 8.42, which makes it a Sell.
- EyePoint Pharmaceuticals 50-day simple moving average is 8.66 while EYPT share price is 8.01, making it a Sell technically.
- EYPT stock price is 8.01 and EyePoint Pharmaceuticals 200-day simple moving average is 15.98, creating a Sell signal.
EYPT Technical Analysis vs Fundamental Analysis
Sell
40
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy or a Sell?
-
EyePoint Pharmaceuticals stock is rated a Sell
The current EyePoint Pharmaceuticals [EYPT] share price is $8.01. The Score for EYPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
EyePoint Pharmaceuticals Stock Info
Market Cap:
428.68M
Price in USD:
8.01
Share Volume:
331.1K
EyePoint Pharmaceuticals 52-Week Range
52-Week High:
30.99
52-Week Low:
5.67
Sell
40
EyePoint Pharmaceuticals (EYPT)
is a Sell
EyePoint Pharmaceuticals Share Price Forecast
-
What is the EyePoint Pharmaceuticals stock price today?
The EyePoint Pharmaceuticals stock price is 8.01 USD today. -
Will EYPT stock go up or go down?
EyePoint Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is EyePoint Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, EyePoint Pharmaceuticals is overvalued.
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 8.01 while EYPT 8-day exponential moving average is 8.20, which is a Sell signal.
- The stock price of EYPT is 8.01 while EyePoint Pharmaceuticals 20-day EMA is 8.40, which makes it a Sell.
- EyePoint Pharmaceuticals 50-day exponential moving average is 8.83 while EYPT share price is 8.01, making it a Sell technically.
- EYPT stock price is 8.01 and EyePoint Pharmaceuticals 200-day simple moving average is 12.03, creating a Sell signal.
Fundamental Analysis of EyePoint Pharmaceuticals
Is EyePoint Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.
Technical Analysis of EyePoint Pharmaceuticals
Should I short EyePoint Pharmaceuticals stock?
- EYPT Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting EyePoint Pharmaceuticals is a Sell
- EyePoint Pharmaceuticals Relative Strength Index (RSI) is 42.06, which suggest EyePoint Pharmaceuticals is oversold
- The Bollinger Bands (25) for EyePoint Pharmaceuticals is (8.06 - 8.9), which suggest EyePoint Pharmaceuticals is a Sell
- The Bollinger Bands (100) for EyePoint Pharmaceuticals is (8.03 - 10.53), which suggest EyePoint Pharmaceuticals is a Sell
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.